Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manoj S

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Biorxiv : the Preprint Server for Biology|June 27, 2020
Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 SpikeLihong Liu, Pengfei Wang, Manoj S Nair, et al.
Nature|January 11, 2022
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2Lihong Liu, Sho Iketani, Yicheng Guo, et al.
Research Square|May 25, 2021
SARS-CoV-2 Infection Causes Dopaminergic Neuron SenescenceYuling Han, Liuliu Yang, Tae Wan Kim, et al.
Nature|June 7, 2021
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variantsJianliang Xu, Kai Xu, Seolkyoung Jung, et al.
JAMA Network Open|April 30, 2021
Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical TrialLee-Ling Lim, Eric S H Lau, Amy W C Fu, et al.
Cell Stem Cell|January 18, 2024
SARS-CoV-2 infection causes dopaminergic neuron senescenceLiuliu Yang, Tae Wan Kim, Yuling Han, et al.
Science Translational Medicine|April 19, 2022
An antibody class with a common CDRH3 motif broadly neutralizes sarbecovirusesLihong Liu, Sho Iketani, Yicheng Guo, et al.
Nature Communications|April 8, 2022
Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19Hengrui Liu, Sho Iketani, Arie Zask, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
Paired heavy and light chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responsesBailey B Banach, Gabriele Cerutti, Ahmed S Fahad, et al.
Cell Reports|September 29, 2021
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responsesBailey B Banach, Gabriele Cerutti, Ahmed S Fahad, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Biorxiv : the Preprint Server for Biology|June 27, 2020
Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 SpikeLihong Liu, Pengfei Wang, Manoj S Nair, et al.
Nature|January 11, 2022
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2Lihong Liu, Sho Iketani, Yicheng Guo, et al.
Research Square|May 25, 2021
SARS-CoV-2 Infection Causes Dopaminergic Neuron SenescenceYuling Han, Liuliu Yang, Tae Wan Kim, et al.
Nature|June 7, 2021
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variantsJianliang Xu, Kai Xu, Seolkyoung Jung, et al.
JAMA Network Open|April 30, 2021
Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical TrialLee-Ling Lim, Eric S H Lau, Amy W C Fu, et al.
Cell Stem Cell|January 18, 2024
SARS-CoV-2 infection causes dopaminergic neuron senescenceLiuliu Yang, Tae Wan Kim, Yuling Han, et al.
Science Translational Medicine|April 19, 2022
An antibody class with a common CDRH3 motif broadly neutralizes sarbecovirusesLihong Liu, Sho Iketani, Yicheng Guo, et al.
Nature Communications|April 8, 2022
Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19Hengrui Liu, Sho Iketani, Arie Zask, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
Paired heavy and light chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responsesBailey B Banach, Gabriele Cerutti, Ahmed S Fahad, et al.
Cell Reports|September 29, 2021
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responsesBailey B Banach, Gabriele Cerutti, Ahmed S Fahad, et al.
Pageof 14